DCM Shriram Fine Chemicals Ashwini Shanker as Additional appointed
DCM Shriram Fine Chemicals (DSFCL) said Ashwini Shanker as Additional has been appointed. The company is valued at about ₹235 crore.
What happened
In a filing with the BSE on 14 November 2026 at 09:16 PM, DCM Shriram Fine Chemicals (DSFCL) said that Ashwini Shanker as Additional has been appointed.
Company snapshot
DCM Shriram Fine Chemicals is a micro-cap company, with a market value of about ₹235 crore.
The stock last traded at ₹27, against a 52-week range of ₹17.28–₹52.5 (48.6% below the high).
Before this filing the shares had moved −3.0% over the month and +5.3% over three months. Average daily turnover over the last 20 sessions was about ₹0.1 crore.
Promoters held 50.11% at the end of Q1 FY27. Foreign institutions owned 1.03% and domestic institutions 11.36%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q3 FY26 | 97 | -1.5 | -0.17 |
| Q4 FY26 | 93 | -3.8 | -0.44 |
| Q1 FY27 | 91 | 2.6 | 0.3 |
What history shows
This is not the company's first management change disclosure: BCEIE has at least 12 earlier filings of this kind on record since May 2026.
After those filings, the stock gained 0.0% on average the next trading day and was up 0.4% on average after five days (11 filings with price data).
Market-wide, 4,563 management change filings with an impact score of 50 or more saw an average next-day move of −0.0%, with 46% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 25 Sept 2026 | Resignation of Mr. Rohit Bhandari as Independent Director of the… | −3.4% | −11.7% |
| 25 Sept 2026 | Resignation of Director/KMP/SMP | −3.4% | −11.7% |
| 25 Sept 2026 | Cessation of Mr. Rohit Bhandari as Independent Director of the… | −3.4% | −11.7% |
| 25 Sept 2026 | Resignation of Mr. Rohit Bhandari as Independent Director of the… | −3.4% | −11.7% |
| 17 Sept 2026 | Resignation of Director/KMP/SMP | +9.8% | +24.5% |
What to watch
- The appointment of a successor and any change in strategy or guidance.
- 14 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.